novartis ceo on new cancer therapy programs
Published 3 years ago • 2.5K plays • Length 4:22Download video MP4
Download video MP3
Similar videos
-
3:43
novartis ceo vas narasimhan on the latest research on a breast cancer drug
-
4:43
novartis ceo: our leukemia drug scemblix is a potential $3 billion plus medicine
-
5:53
novartis expects 'strong momentum' going into second half, says ceo vasant narasimhan
-
7:51
watch cnbc's full interview with novartis ceo vas narasimhan
-
0:57
novartis global ceo vas narasimhan: ai's impact on pharma and clinical trial realities | n18s
-
2:05
ceo of swiss drugmaker novartis outlines some major industry trends for 2024
-
4:16
novartis ceo vas narasimhan: our medicines are starting to take market share and deliver on promises
-
5:29
revolutionary new cancer treatment at nyu
-
9:48
novartis ceo: growth drivers performing well, but product exclusivity losses creating headwinds
-
43:50
vasant narasimhan, chief executive officer, novartis | bsr18
-
3:48
new cancer drug data announced: here's what to know
-
7:41
novartis ceo on company's approach to covid-19 treatment
-
4:11
novartis ceo on esg: pandemic has been a reset for pharma's reputation
-
2:18
novartis ceo: we're moving toward filing covid drug from molecular partners with fda
-
6:28
novartis ceo discusses developing a new covid-19 treatment
-
6:12
novartis ceo: expect continued growth in 2023
-
6:21
advances in cancer therapy: researching ways to use the body's immune system to fight cancer | cnbc
-
3:47
novartis ceo: demand has surged for therapeutics
-
1:13
novartis cancer drug is approved with $475,000 price tag
-
6:15
coronavirus: novartis ceo vas narasimhan on the timeline for coronavirus treatments
-
12:38
health care in a post-pandemic world with vas narasimhan novartis at cnbc evolve global summit 2021
-
3:29
novartis generated $40 billion in innovative medicine sales, says ceo